100 years of Lewy pathology

@article{Goedert2013100YO,
  title={100 years of Lewy pathology},
  author={M. Goedert and M. Spillantini and K. Tredici and H. Braak},
  journal={Nature Reviews Neurology},
  year={2013},
  volume={9},
  pages={13-24}
}
In 1817, James Parkinson described the symptoms of the shaking palsy, a disease that was subsequently defined in greater detail, and named after Parkinson, by Jean-Martin Charcot. Parkinson expected that the publication of his monograph would lead to a rapid elucidation of the anatomical substrate of the shaking palsy; in the event, this process took almost a century. In 1912, Fritz Heinrich Lewy identified the protein aggregates that define Parkinson disease (PD) in some brain regions outside… Expand
The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future.
  • S. Fahn
  • Psychology, Medicine
  • Parkinsonism & related disorders
  • 2018
TLDR
It took almost 100 years before a meaningful advance occurred in any basic science understanding of Parkinson disease (PD) following James Parkinson's description in 1817, but following 40 years of the dopa/dopamine era, the authors have entered the era of alpha-synuclein, the protein present in Lewy bodies. Expand
An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease
  • T. Uchihara
  • Medicine, Biology
  • Neuropathology : official journal of the Japanese Society of Neuropathology
  • 2017
TLDR
This “structural template” hypothesis may explain why: (i) some selective groups are prone to develop Lewy pathology; (ii) their clinical manifestations are vague and generalized without somatotopic accentuation; (iii) distal axons and terminals are preferentially affected early, which is clinically detectable as reduced myocardial uptake of meta‐iodobenzylguanidine in PD/DLB. Expand
Lewy and his inclusion bodies: Discovery and rejection
Fritz Jacob Heinrich Lewy described the pathology of Paralysis agitans [Parkinson disease] and was the first to identify eosinophilic inclusion bodies in neurons of certain brain nuclei, later knownExpand
α-Synuclein and Lewy pathology in Parkinson's disease.
TLDR
These recent findings open up new avenues of investigation into the molecular pathogenesis of Parkinson's disease, and future work will need to identify the most toxic conformations of α-synuclein and define their relationship to Lewy pathology. Expand
Lewy pathology in Parkinson’s disease consists of a crowded organellar, membranous medley
TLDR
The majority ofLewy pathology including Lewy bodies and Lewy neurites primarily consists of a crowded membranous medley of vesicular structures and dysmorphic organelles, and in the postmortem brain of Parkinson’s patients a subcellular protein-lipid compartmentalization not previously described in Lewy pathology is discovered. Expand
Progressive models of Parkinson's disease : behavioural and neurochemical analyses
TLDR
The cNurr1 DATCreER model recapitulated early pathological features of PD, including a progressively reduced expression of several dopaminergic markers in the striatum and ventral midbrain, reduced striatal levels of dopamine and its metabolites, a dopamine fiber pathology not accompanied by midbrain dopamine cell death, and profound motor symptoms. Expand
Parkinson's disease
TLDR
The complexity of Parkinson's disease is accompanied by clinical challenges, including an inability to make a definitive diagnosis at the earliest stages of the disease and difficulties in the management of symptoms at later stages. Expand
Dementia with Lewy bodies: a common condition in nursing homes?
  • J. Morley
  • Medicine
  • Journal of the American Medical Directors Association
  • 2013
TLDR
Dementia with Lewy bodies overlaps or coexists with Alzheimer disease (Lewy body variant of Alzheimer disease) and Parkinson disease dementia and the symptoms attributed to DLB are mainly due to loss of cholinergic neurons and dopamine. Expand
Neurophysiology of the brain stem in Parkinson's disease.
TLDR
A brief review of neuronal electrophysiological findings in the SNpc and DMV in PD proposes that PD pathology is governed by regional or cell-restricted factors as the leading cause of nigral neuronal degeneration. Expand
200 Years of Parkinson’s disease: what have we learnt from James Parkinson?
TLDR
A biography of James Parkinson's remarkable life is provided and key observation over the next 2 centuries, included the recognition of the link between the substantia nigra and PD and the discoveries of dopamine deficiency in patients with PD are reviewed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 197 REFERENCES
Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.
TLDR
It is concluded that nigral neuronal loss is slow and shows considerable variation in PD, and provides no support for a primary pathogenic role of LBs as neither their distribution nor density was associated with the severity of nigral cell loss. Expand
Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered
TLDR
This cross‐sectional study originally was performed on 168 autopsy cases using material from 69 incidental cases and 41 clinically diagnosed PD patients as well as 58 age‐ and gender‐matched controls to critically reconsidered and discussed. Expand
Pathology associated with sporadic Parkinson's disease--where does it end?
TLDR
19 of the 301 cases with PD-related pathology displayed a pathological distribution pattern of Lewy neurites and Lewy bodies that diverged from the staging scheme described above, and most of the divergent cases had advanced concomitant Alzheimer's disease-related neurofibrillary changes. Expand
A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death
TLDR
While akinesia and rigidity were linked with the neuronal loss, the percentages of Lewy body bearing neurons and of alpha-synuclein immunoreactive neurons in the substantia nigra were not correlated with the symptoms or the disease duration, and appeared stable, and indicated that, during the whole course of the disease, the destruction of the Lewy bodies was equal to their production. Expand
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease
TLDR
iLBD is preclinical PD and that the lack of symptoms is due to subthreshold pathology, and a marker for dopaminergic and noradrenergic neurons, tyrosine hydroxylase, was used to determine if there were changes similar to those found in PD. Expand
Lewy body pathology in Alzheimer’s disease
TLDR
The observation ofLewy bodies in familial AD cases suggests that like neurofibrillary tangles, the formation of Lewy bodies can be induced by the pathological state caused by Aβ-amyloid over-production. Expand
Friedrich Heinrich Lewy (1885–1950) and His Work
  • B. Holdorff
  • Medicine, Psychology
  • Journal of the history of the neurosciences
  • 2002
TLDR
An identification of diffuse Lewy body disease or dementia followed much later, and it seems that their importance was seen only after Lewy's death, long after Tretiakoff's initial naming of the “corps de Lewy”. Expand
Neuroanatomy and pathology of sporadic Parkinson's disease.
TLDR
The authors analyze the pathoanatomy of sPD in the nervous system at various neuropathological stages and summarize the potential functional consequences of the lesions. Expand
Spinal cord lesions in sporadic Parkinson’s disease
TLDR
It could be concluded that, within the central nervous system, sporadic Parkinson’s disease does not begin in the spinal cord. Expand
Presenile dementia with Alzheimer-, Pick- and Lewy-body changes
TLDR
Nosologically, this case may represent either a combination of Alzheimer's disease, Pick's disease and idiopathic Parkinsonism with “Lewy-like-bodies” in the cerebral cortices, or a single disease. Expand
...
1
2
3
4
5
...